Molecular Imaging

Spectrum Dynamics Launches VERITON-CT 400 Enhancement

MORGES, Switzerland, July 20, 2026 Spectrum Dynamics Medical has announced the launch of the All-Energy Enhancement for its FDA-cleared,...

By cGxPwire Editor
July 22, 2026

Bio-Pharma

Telix Completes Phase 3 Enrollment for Illuccix in Japan

MELBOURNE, Australia, and TOKYO, Japan, July 17, 2026 Telix Pharmaceuticals has completed patient enrollment in its pivotal Phase 3...

By cGxPwire Editor
July 20, 2026

Bio-Pharma

Telix and United Imaging Partner to Advance AI-Driven Theranostics

MELBOURNE, Australia; INDIANAPOLIS, Indiana; and HOUSTON, Texas, June 2, 2026 Telix Pharmaceuticals and United Imaging Healthcare North America have...

By cGxPwire Editor
June 3, 2026

MedTech

Telix Expands PSMA-PET Imaging in Prostate Cancer Care

MELBOURNE, Australia, and INDIANAPOLIS, May 15, 2026 Telix Pharmaceuticals Limited announced new strategic collaborations with EDAP TMS S.A. and...

By cGxPwire Editor
May 16, 2026

.Clinical

Bayer PET Tracer Shows Promise in Amyloidosis Study

BERLIN, Germany / WHIPPANY, N.J., May 7, 2026 Bayer announced positive topline results from the pivotal Phase III REVEAL...

By cGxPwire Editor
May 8, 2026

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

Bio-Pharma

Mabwell Advances SST001 PET Tracer to Phase I Trial

SHANGHAI, CHINA, April 14, 2026 Mabwell (688062.SH) has announced that SST001 (18F-FD4), an innovative α-synuclein-targeted PET tracer developed by...

By cGxPwire Editor
April 15, 2026

Bio-Pharma

Cu-64 SAR-bisPSMA Doubles Prostate Cancer Detection

SYDNEY, Australia, Feb. 16, 2026 — Clarity Pharmaceuticals announced new clinical data from the Co-PSMA Investigator-Initiated Trial demonstrating that...